Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01604252 · ClinicalTrials.gov registry record
An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)
A clinical trial, sponsored by Genentech.
- Terminated
- Registry status
- 503
- Enrollment target
NCT01604252: Clinical Trial study, sponsored by Genentech.
NCT01604252 is a clinical trial that was terminated before completion, run by Genentech. The registered enrollment target is 503 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01604252 was terminated before completion, sponsored by Genentech.
- TERMINATED
- Registry status
- 503 participants
- Enrollment target
Study Summary
This multi-center, prospective, observational cohort study will evaluate the effectiveness, safety and utilization of treatments in patients with advanced basal cell carcinoma and basal cell carcinoma nevus syndrome. The total study duration is anticipated to be a maximum of 8 years, including 3 years for patient recruitment and 5 years follow-up.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 503 participants |
| Start Date | 2012-06-20 |
| Est. Completion | 2017-04-28 |
Why NCT01604252 stopped before completion
NCT01604252 is an observational study that tracks outcomes without assigning an intervention. The registered 503 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01604252 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01604252 about?
NCT01604252 is a clinical study titled "An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)". This multi-center, prospective, observational cohort study will evaluate the effectiveness, safety and utilization of treatments in patients with advanced basal cell carcinoma and basal cell carcinoma nevus syndrome. The total study duration is anticipated to be a maximum of 8 years, including 3 yea...
What is the current status of trial NCT01604252?
This trial is currently terminated. The enrollment target is 503 participants. The study started on 2012-06-20. Estimated completion is 2017-04-28.
Who is sponsoring clinical trial NCT01604252?
This trial is sponsored by Genentech, which has 332 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05143931 · 503 participants · NA
Avoid and Resist Strategies for Weight Management
- NCT05846282 · 504 participants · NA
Students Rising Above: Offsetting the Health and Mental Health Costs of Resilience
- NCT06072131 · 504 participants · Phase 3
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
- NCT06736522 · 504 participants · NA
Future Leaders Program: Testing a Youth Leadership, Engagement, and Mindfulness Program
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI